Suchergebnisse - "Garrido-Laguna, Ignacio"

PubPharm (152)

1

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer

enthalten in: Cancers | 2024

von Gardner, F. | Wainberg, Z. | Fountzilas, C. | +9

2

Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma

enthalten in: Gastroenterology | 2024

von Wattenberg, M. | Colby, S. | Garrido-Laguna, I. | +16

3

Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma : results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021)

enthalten in: EClinicalMedicine | 2024

von Li, D. | Loriot, Y. | Burgoyne, A. | +9

4

Durable response to first-line PARP inhibition in BRCA-mutated metastatic cholangiocarcinoma : case report

enthalten in: Journal of gastrointestinal oncology | 2023

von Smith, J. | Sama, S. | Florou, V. | +2

5

Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors

enthalten in: Journal for immunotherapy of cancer | 2023

von Bauer, T. | Santoro, A. | Lin, C. | +16

6

Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Florou, V. | Elliott, A. | Bailey, M. | +11

7

Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Beatty, G. | Delman, D. | Yu, J. | +10

8

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors

enthalten in: British journal of cancer | 2023

von El-Khoueiry, A. | Clarke, J. | Neff, T. | +12

9

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden

enthalten in: Journal for immunotherapy of cancer | 2023

von Florou, V. | Floudas, C. | Maoz, A. | +14

10

Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2023

von Benson, A. | Venook, A. | Al-Hawary, M. | +40

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]